Faculty, Staff and Student Publications
Publication Date
5-21-2025
Journal
Nano Letters
DOI
10.1021/acs.nanolett.5c01897
PMID
40357748
PMCID
PMC12398074
PubMedCentral® Posted Date
8-31-2025
PubMedCentral® Full Text Version
Author MSS
Abstract
Glioblastoma (GBM) remains difficult to treat due to poor drug delivery across the blood-brain barrier and an immunosuppressive tumor microenvironment (TME). Tumor-suppressive microRNAs (miRNAs) offer a promising strategy to reprogram both tumor cells and the TME, but inefficient delivery systems limit their clinical application. We previously reported that tumor-suppressive miR-138 regresses tumor growth in preclinical GBM models. Here, we demonstrate that trypsin digestion of extracellular vesicles (EVs) enhances labeling efficiency with folate (FA), enhancing selective targeting of folate receptor (FR)-positive GBM cells and enabling simultaneous targeting of tumor-associated macrophages (TAMs). FA-labeled trypsinized EVs (tEVs) loaded with miR-138 inhibit tumor growth, depolarize TAMs, and enhance antitumor immunity. This study represents the first preclinical attempt to modulate tumor cells and innate immunity via miRNA-loaded tEVs, offering a novel and more effective therapeutic approach to GBM treatment.
Keywords
Glioblastoma, MicroRNAs, Extracellular Vesicles, Humans, Tumor Microenvironment, Animals, Mice, Tumor-Associated Macrophages, Cell Line, Tumor, Brain Neoplasms, Folic Acid, Glioblastoma (GBM), Tumor-associated macrophages (TAMs), Extracellular vesicle (EV), microRNA-138 (miR-138), Trypsin, Tumor microenvironment (TME)
Published Open-Access
yes
Recommended Citation
Nguyen, Grace H; Noh, MinHye; Kang, Jin Muk; et al., "Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA" (2025). Faculty, Staff and Student Publications. 5099.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5099
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons